Loading…
Penumbra, Inc. is projected to rise to $423.25 by 2027, a +32% move from its current price of $319.83. PEN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $317.50 | $320.03 | $322.57 | +0.06% |
| Aug 2 | $316.66 | $320.23 | $323.83 | +0.12% |
| Aug 3 | $316.06 | $320.42 | $324.85 | +0.19% |
| Aug 4 | $315.58 | $320.62 | $325.74 | +0.25% |
| Aug 5 | $315.19 | $320.82 | $326.55 | +0.31% |
| Aug 6 | $314.85 | $321.02 | $327.31 | +0.37% |
| Aug 7 | $314.56 | $321.22 | $328.02 | +0.43% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $314.56 | $321.22 | $328.02 | +0.43% |
| Week 2 | $313.19 | $322.61 | $332.32 | +0.87% |
| Week 3 | $312.47 | $324.01 | $335.99 | +1.31% |
| Week 4 | $312.07 | $325.42 | $339.35 | +1.75% |
| Week 5 | $311.87 | $326.84 | $342.51 | +2.19% |
| Week 6 | $311.83 | $328.25 | $345.54 | +2.63% |
| Week 7 | $311.90 | $329.68 | $348.47 | +3.08% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Penumbra, Inc. is a healthcare company that designs, develops, manufactures, and markets medical devices in the United States and internationally.
Its portfolio includes computer-assisted vacuum thrombectomy and peripheral thrombectomy products, such as the Indigo System for power aspiration of thrombus in the body, Lightning Flash, a mechanical thrombectomy system, Lightning Bolt 7, an arterial thrombectomy system, and CAT RX. It also provides access products including guide catheters and Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25 brands; the Penumbra System, an integrated mechanical thrombectomy system with reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing and pump, and other components under brands such as RED, SENDit, JET, ACE, BMX, Max, and 3D Revascularization Device; and neuro embolization coiling systems that include the Penumbra Coil 400 and related coils, as well as peripheral embolization products like the Ruby Embolization Platform and related devices. Further, it offers neurosurgical tools such as the Artemis Neuro Evacuation Device and sells its products through direct sales organizations and distributors.
The company was incorporated in 2004 and is based in Alameda, California.
Penumbra, Inc. (PEN) is a healthcare company with a current price of $316.50 and a market capitalization of $12.45B, ranked 769. It operates in the Healthcare sector and the stock displays a bullish longer-term outlook in the provided forecast, with average prices rising through 2026 to 2050 and multiple year milestones noted.
The current price is $316.50 and the market cap is $12.45B, with a rank of 769. The forecast shows a bullish trajectory over the long term, with 2026 average price at $316.50, and higher averages projected for 2027 through 2050, including 2030 at $532.97, 2040 at $1,381.28, and 2050 at $2,318.27.
A major floor 1.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.4% away) — a key level to hold.
Price is pressing into resistance (0.1% away) — a breakout level to watch.
A major ceiling 5.2% above — clearing it would confirm fresh momentum.
Key PEN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PEN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $319.63 | Buy | $319.52 | Buy |
| MA 10 | $318.63 | Buy | $318.97 | Buy |
| MA 20 | $318.31 | Buy | $318.57 | Buy |
| MA 50 | $319.20 | Buy | $319.90 | Sell |
| MA 100 | $324.74 | Sell | $320.60 | Sell |
| MA 200 | $315.29 | Buy | $312.01 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.15 | Neutral |
| Stoch RSI (14) | 90.78 | Sell |
| CCI (20) | 115.15 | Buy |
| Williams %R (14) | -7.75 | Info |
| MACD (12,26,9) | 0.41 | Buy |
| ROC (12) | 1.13 | Buy |
| Bollinger %B (20,2) | 0.84 | Neutral |
| Stochastic %K (14) | 92.25 | Sell |
| TRIX (15) | -0.01 | Sell |
| Awesome (5,34) | 1.83 | Buy |
| Ultimate (7,14,28) | 66.97 | Neutral |
| Momentum (10) | 0.23 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 320.58 | Sell |
| ADX (14) | 11.53 | Neutral |
| ATR (14) | 0.88 | Info |
The 30-day technical picture is bullish overall.
RSI(14) is 40, with the 50-day simple moving average at $319.66 and the 200-day simple moving average at $313.41. These moving averages place current price action near resistance and slightly above the short-term average, indicating modest upside potential in the near term.
Near-term support is $315.46 and resistance is $321.06. The 30-day range runs from $300.12 to $333.77, and the annualized volatility is 20%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $300.97 | $319.83 | $416.13 | 0% | Neutral | |
| $347.04 | $423.25 | $539.41 | +32% | Bullish | |
| $376.22 | $467.57 | $612.27 | +46% | Bullish | |
| $421.50 | $532.01 | $711.64 | +66% | Bullish | |
| $429.33 | $549.25 | $748.04 | +72% | Bullish | |
| $436.77 | $565.62 | $782.59 | +77% | Bullish | |
| $519.81 | $680.80 | $955.42 | +113% | Bullish | |
| $588.55 | $778.98 | $1,107.41 | +144% | Bullish | |
| $639.61 | $855.00 | $1,230.07 | +167% | Bullish | |
| $697.53 | $941.27 | $1,369.31 | +194% | Bullish | |
| $1,019.22 | $1,434.62 | $2,187.37 | +349% | Bullish | |
| $1,613.36 | $2,435.72 | $3,981.36 | +662% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $300.97 | $319.83 | $372.52 | +0.00% |
| August 2026 | $283.16 | $330.17 | $392.35 | +3.23% |
| September 2026 | $288.57 | $338.41 | $405.91 | +2.49% |
| October 2026 | $283.47 | $333.95 | $403.54 | -1.32% |
| November 2026 | $280.85 | $332.12 | $403.75 | -0.55% |
| December 2026 | $286.91 | $340.45 | $416.13 | +2.51% |
Click any year to see its month-by-month PEN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, PEN could reach as high as $416.13, with a base case around $319.83 and support toward $300.97 — roughly 0% from $319.83. Price action looks broadly range-bound.
Expect PEN to range from $347.04 to $539.41 through 2027. The $423.25 average target implies a +32% move from current prices. That is up +32% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The PEN price prediction for 2028 points to an average of $467.57 (low $376.22, high $612.27) — a potential gain of +46% on today's $319.83. Momentum favours further upside here.
In 2029, PEN is projected to trade between $421.50 and $711.64, averaging $532.01 — a potential gain of +66% from today's $319.83. That is up +14% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Penumbra, Inc.'s 2030 outlook centres on $549.25, within a $429.33 to $748.04 range. That is up +3% on the projected 2029 average. That marks a +72% change versus current levels. Momentum favours further upside here.
By 2031, PEN could reach as high as $782.59, with a base case around $565.62 and support toward $436.77 — roughly +77% from $319.83. Buyers look set to stay in control over this stretch.
Expect PEN to range from $519.81 to $955.42 through 2032. The $680.80 average target implies a +113% move from current prices. That is up +20% on the projected 2031 average. Momentum favours further upside here.
The PEN price prediction for 2033 points to an average of $778.98 (low $588.55, high $1,107.41) — a potential gain of +144% on today's $319.83. Buyers look set to stay in control over this stretch.
In 2034, PEN is projected to trade between $639.61 and $1,230.07, averaging $855.00 — a potential gain of +167% from today's $319.83. That is up +10% on the projected 2033 average. Momentum favours further upside here.
Penumbra, Inc.'s 2035 outlook centres on $941.27, within a $697.53 to $1,369.31 range. That is up +10% on the projected 2034 average. That marks a +194% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, PEN could reach as high as $2,187.37, with a base case around $1,434.62 and support toward $1,019.22 — roughly +349% from $319.83. Momentum favours further upside here.
Expect PEN to range from $1,613.36 to $3,981.36 through 2050. The $2,435.72 average target implies a +662% move from current prices. That is up +70% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in PEN today (≈ 3.126661 PEN) could be worth
$7,615.68
+$6,615.68 (+662%) by 2050 · US Dollar
Based on the average projected PEN price of $2,435.72 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PENwould be worth at today's price.
$1,000 invested in PEN on Jul 30, 2025 (≈ 3.933755 PEN) would be worth
$1,258.13
+$258.13 (+25.8%) today · 1.26× · US Dollar
Based on a PEN entry price of $254.21 vs. today's $319.83.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $317.9 | $1,006.07 | +0.6% |
| 1 month ago | $315.75 | $1,012.92 | +1.3% |
| 3 months ago | $325.33 | $983.09 | -1.7% |
| 6 months ago | $358.17 | $892.96 | -10.7% |
| 1 year ago | $254.21 | $1,258.13 | +25.8% |
| All time (5.0y) ago | $265.29 | $1,205.59 | +20.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PEN forecast.
Our base-case forecast reaches $640.00 around 2032.
Implied market cap at $640.00: $25.17B
The multi-year forecast shows a continued bullish trajectory, with 2026 average pricing at $316.50 and 2027 at $416.33, followed by 2028 at $461.51, 2029 at $521.23, and 2030 at $532.97. These steps illustrate a rising path with increasing confidence in higher price levels over time.
By 2040, the forecast projects an average of $1,381.28 and a maximum of $2,106.42, representing an estimated ROI of 336.4% and a bullish sentiment. By 2050, the forecast envisions an average of $2,318.27 and a maximum of $3,789.87, with an ROI of 632.5% and continued bullish sentiment.
These are estimates and not guarantees; the outlook carries inherent uncertainty and depends on numerous factors that can influence future prices.
Tap a question to reveal the answer.
2030 min $416.49, avg $532.97, max $726.13; ROI 68.4%; sentiment BULLISH.
The forecast shows a bullish path from 2027 onward, with 2027 avg $416.33 (ROI 31.5%), 2028 avg $461.51 (ROI 45.8%), 2030 avg $532.97 (ROI 68.4%), 2040 avg $1,381.28 (ROI 336.4%), and 2050 avg $2,318.27 (ROI 632.5%), indicating significant upside potential in the projections.
Yes. The 2035 forecast shows min $676.69, avg $913.33, max $1,328.98, indicating a maximum above $1,000.
Current price is $316.50 and market cap is $12.45B.
The near-term setup is bullish with RSI(14) at 40, SMA50 at $319.66, SMA200 at $313.41, support at $315.46, resistance at $321.06, and a 30-day range of $300.12 to $333.77; annualized volatility is 20%.
Penumbra, Inc. Community Discussion
0Share your Penumbra, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.